{"id":286327,"date":"2023-03-02T08:40:42","date_gmt":"2023-03-02T14:40:42","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=286327"},"modified":"2023-03-01T15:17:33","modified_gmt":"2023-03-01T21:17:33","slug":"dozen-ags-sue-fda-regulation-abortion-pill","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/dozen-ags-sue-fda-regulation-abortion-pill\/","title":{"rendered":"A dozen pro-abortion AGs sue FDA for ‘excessive regulation’ of abortion pill"},"content":{"rendered":"
<\/div>

A new abortion pill lawsuit filed<\/a>\u00a0by a group of pro-abortion attorneys general against the U.S. Food and Drug Administration (FDA) claims the government agency “unnecessarily singl[ed] out the abortion drug mifepristone for excessive regulation” by keeping it under the FDA’s REMS safety system.\u00a0The abortion pill is estimated to have ended the lives of over 500,000 preborn babies in 2020<\/a> alone.<\/p>\n

“The Attorneys General are also seeking a preliminary injunction, asking the court to stop FDA enforcement of the REMS while the lawsuit is pending,” the group’s press release<\/a> claimed.\u00a0The suit was led by pro-abortion Oregon AG Ellen Rosenblum<\/a>\u00a0and Washington AG Bob Ferguson, later adding 10 others. In their complaint<\/a>, the 12 state AGs contend that the “FDA has continued to hamper access by singling out mifepristone… for a unique set of restrictions known as a Risk Evaluation and Mitigation Strategy (REMS).”<\/p>\n

The FDA’s website<\/a> states that REMS is a “drug safety program that the [FDA] can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks. REMS are designed to reinforce medication use behaviors and actions that support the safe use of that medication. While all medications have labeling that informs health care stakeholders about medication risks, only a few medications require a REMS.”<\/p>\n

FDA kept abortion pill under REMS during tenure of pro-abortion Democrat presidents\u00a0<\/strong><\/p>\n

The abortion pill mifepristone (Mifeprex) was approved under the leadership of pro-abortion then-President Bill Clinton in 2000.<\/p>\n

Live Action News has\u00a0previously<\/a>\u00a0detailed the FDA\u2019s concerns over the safety of the abortion pill in past years, which included a serious infection and the death of several women shortly after the regimen was approved. This is why in\u00a0April 2011, under President Barack Obama’s FDA, the agency\u00a0determined<\/a>\u00a0that the safety requirement known as\u00a0REMS<\/a>\u00a0was\u00a0necessary<\/em>\u00a0for mifepristone.<\/p>\n